Diagnamed Holdings Corp. (CSE:DMED)
0.0400
+0.0050 (14.29%)
Feb 18, 2025, 4:00 PM EST
Diagnamed Holdings Statistics
Total Valuation
CSE:DMED has a market cap or net worth of CAD 2.40 million. The enterprise value is 2.24 million.
Market Cap | 2.40M |
Enterprise Value | 2.24M |
Important Dates
The last earnings date was Friday, January 31, 2025.
Earnings Date | Jan 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:DMED has 80.05 million shares outstanding. The number of shares has increased by 2.38% in one year.
Current Share Class | n/a |
Shares Outstanding | 80.05M |
Shares Change (YoY) | +2.38% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 12.43% |
Owned by Institutions (%) | n/a |
Float | 62.26M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.47 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.43
Current Ratio | 0.43 |
Quick Ratio | 0.42 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -97.41% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 253.91% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is -2.30, so CSE:DMED's price volatility has been lower than the market average.
Beta (5Y) | -2.30 |
52-Week Price Change | +33.33% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 49.21 |
Average Volume (20 Days) | 271,050 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -673,295 |
Pretax Income | -501,057 |
Net Income | -501,057 |
EBITDA | n/a |
EBIT | -673,295 |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Cash & Cash Equivalents | 162,146 |
Total Debt | n/a |
Net Cash | 162,146 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -265,167 |
Book Value Per Share | -0.00 |
Working Capital | -265,167 |
Cash Flow
Operating Cash Flow | -444,817 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:DMED does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.38% |
Shareholder Yield | -2.38% |
Earnings Yield | -20.86% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |